CVE-2026-123052 — MEDIUM Vulnerability
CVE-2026-123052 is a MEDIUM severity security vulnerability (CVSS 4.7/10) affecting affected software system. Technical vector analysis shows that an attacker can exploit this flaw via local access (AV:L) without authentication (PR:N) with zero user interaction (UI:N), allowing unauthorized disclosure of sensitive data (C:H).
📄 Official NVD / MITRE Original Record Text
The CeliachiaRL integration component distributed with Farmasimplex uses shared OAuth credentials across multiple customer installations. An attacker who obtains the credentials from one installation could reuse them against services associated with other installations, potentially leading to unauthorized access to sensitive information or modification of integration data.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
CVE-2026-123052
CVSS 4.7/10 · MEDIUM · 17.11.2026
Vector: CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:U
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
🎯 WHAT IS THIS VULNERABILITY?
Summary: The CeliachiaRL integration component distributed with Farmasimplex uses shared OAuth credentials across multiple customer installations. An attacker who obtains the credentials from one installation could reuse them against services associated with other installations, potentially leading to unauthorized access to sensitive information or modification of integration data.
⚡ ATTACK CHAIN
Local/physical access | no authentication required | no user interaction | low complexity.
🌍 REAL WORLD IMPACT
All confidential data readable/stealable.
🛡️ REMEDIATION
→ Apply the vendor-released patch immediately.
→ Add WAF rule, create IDS alert for anomalous traffic.
⚠️ URGENCY
📋 Routine update cycle (30 days)
────────────────────────────────────────
[Kural Tabanlı Otomatik Güvenlik Analizi]